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Alteration in the Expression of
Compartmentation: in vitro Studies
D. D.

ii

CLARKE

and S.

BERL

Glutamic acid and glutamine are present in unusually large concentrations
in brain. The only known enzymatic mechanism which has been reported
for the synthesis of glutamine is that catalysed by glutamine synthetase
(E.C.6.3.1.2). These amino acids provide a very useful probe for studying
precursor-product relationships in brain tissue in vivo. It is evident that the
non-steady state situation presented by injection of a single dose of inhibitor
followed by a tracer dose of a labelled precursor at some later time-a
practice which has been used extensively in previous attempts to clarify the
effects of metabolic inhibitors-makes it rather difficult to interpret the
results. In vitro preparations are an attractive way to avoid some of these
problems. In addition, there have been cases where a labelled precursor
injected intravenously or intraperitoneally, for example alanine, was first
metabolized to glucose with scrambling of the label before entering the brain
(Koeppe and Hahn, 1962).
Cremer (1964) had reported her failure to demonstrate compartmentation
of glutamate metabolism in brain slices with [U- 14 C]glutamate. Our early
attempts to demonstrate specific radioactivity ratios of glutamine/glutamate
greater than 1 using guinea-pig brain slices were equally unsuccessful.
[U- 14 C]Aspartate was used in the hope of avoiding problems caused by
adherence of medium to the slices. Such a medium would contain amino acid
of very high specific radioactivity as tracer quantities with no carrier, were
added to the medium.
Variations of the incubation conditions (cf. Table 8.1) lead to the finding
that preincubation of the slices at 37°C for 10 min followed by transfer to
fresh medium and incubation in the presence of [U- 14 C]aspartate yielded
glutamine of specific radioactivity greater than glutamic acid (2·80 + 0·40)
(Berl et al., 1968). If the tissues were prepared at room temperature instead
of at 0°C the relative specific radioactivity of glutamine was greater than
1 without transferring the slices to fresh medium (1·25 + 0·11). After
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transfer to fresh medium the relative specific radioactivity of glutamine was
even higher (3·41 + 0·27). The labelling of glutamate was not changed very
much as the incubation conditions were varied but that of glutamine was
very sensitive to them.
Once the appropriate conditions for demonstrating compartmentation of
the glutamate-glutamine system in vitro were found, it was possible to study
this phenomenon with other precursors and with varying incubation conditions. [U- 14 C]Glutamate itself yielded glutamine with a relative specific
radioactivity greater than 1 (Table 8.1 ). This might have been due to glutamate
entering and traversing the tricarboxylic acid cycle before entry into glutamine. Two approaches were used to rule this out as an important consideration. One of these was the use of [1- 14 C]glutamate since this substance loses
its label in traversing the tricarboxylic acid cycle. This had been demonstrated
previously by us (Waelsch et al., 1964) and by Haslam and Krebs (1963),
although it was once called into question by Cohen et al. (1962). They have
since retracted this claim (Simon et al., 1968). [1- 14 C]Glutamate gave
glutamine with a relative specific radioactivity ratio greater than 1 (Berl
et al., 1970). This confirmed the opinion that cycling of label was not an
important factor in obtaining these results.
Another approach was decarboxylation of the glutamate and glutamine
recovered after incubating brain slices with [U- 14 C]glutamate. These did
show slight changes in distribution of the label between C-1 and the rest of
the molecule as compared to the starting material but the results did not
suggest that cycling of the label contributed importantly to the labelling of
glutamine (Nicklas et al., 1969). When the glutamate and glutamine recovered
after incubation of brain slices with [U- 14 C]aspartate was decarboxylated a
very interesting result was obtained. C-1 of these samples contained 37·2 +
1·3% (N = 14) which is a significantly greater percentage of label than the
theoretically predicted 33·3%. This raised the possibility that the tricarboxylic
acid cycle in brain was functioning asymmetrically, in the conversion of
succinyl CoA to malate or oxaloacetate. Such behaviour could explain the
results obtained.
Various tests of this hypothesis were considered and one that allowed it
to be ruled out was the study of the labelling of aspartate by [1- 14 C]acetate.
If the steps of the cycle from succinyl-CoA to malate were functioning
asymmetrically in the direction to produce the results previously mentioned
with [U- 14 C]aspartate the aspartate isolated from slices incubated with
[1- 14 C]acetate should have had greater than 50% of the label in C-1. Instead
C-4 had 60% of the label and C-1 had 40% (Nicklas et al., 1969). Now, of
course 50% of the label in C-1 and in C-4 is the normally predicted outcome
of the experiment after passage through the symmetrical intermediates
succinate and fumarate so there is still a dissymmetric labelling of aspartate.
Both sets of data can be explained if oxaloacetate exchanges unequally with
pyruvate and C0 2 in the pyruvate carboxylase reaction. In our experiments
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there is an excess of glucose so that unlabelled pyruvate acts to dilute the
lower three carbon atoms of oxaloacetate to a greater extent than C0 2 no
matter what the labelled precursor. With a deficiency of glucose quite the
opposite result might be anticipated and in fact has been observed by Haslam
and Krebs (1963).
A side issue which this idea of a dissymmetric operation of the lower half
of the tricarboxylic acid cycle made us look into was the aGtion 0f fumarate
hydratase (E.C.4.2.1.2). We wished to study an unsymmetrically labelled
fumarate and in the course of these studies found that monofluorofumarate
was a substrate for fumarate hydratase (Clarke et al., 1968). A similar finding
was reported at the same time by Teipel et al. (1968). We found too that
difluorofumarate was a substrate for fumarate hydratase (unpublished observations) and this was independently reported by Nigh and Richards (1969).
In both of these reactions fluoride ion is eliminated (Fig. 8.1 ).
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8.1 Elimination of fluoride from w-F-odd chain fatty acids and 4-F-glutamate via
the tricarboxylic acid cycle.
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Fluorosuccinate has been shown to be a substrate for succinic dehydrogenase
which converts it into fluorofumarate (Brodie and Nichols, 1970). If fluoropropionate can be converted to fluorosuccinate we have a means of eliminating
fluoride which, while toxic, is many orders of magnitude less toxic than
fluoroacetate or fluorocitrate. This could explain the low toxicity of omegafluoro-odd chain fatty acids since these would be expected to be degraded to
fluoropropionate by the fatty acid degrading enzymes. In addition 4-fluoroglutamate has been reported to be relatively non-toxic. (Tolman and Veres,
1967). If it is converted by transamination to 4-fluoro-oxoglutarate and then
to monofluorosuccinate it also could be metabolized via the tricarboxylic acid
cycle with the elimination of fluoride ion (Fig. 8.1).
Fluoroacetate and fluorocitrate are well known for their neurotoxic action
at extremely low concentrations. However the explanation originally offered
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for their toxic action on the nervous system (Peters, 1957) has been questioned
in recent years. Peters indicated that fluoroacetate was converted to fluorocitrate by 'lethal synthesis' and fluorocitrate is a competitive inhibitor of
aconitase. Studies with brain homogenates where citrate accumulation was
demonstrated backed up this postulate. However some in vivo studies failed
to find very significant accumulations of citrate in fluoroacetate poisoned
animals (see Lahiri and Quastel, 1963). The most precise of the recent studies
is from Lowry's laboratory (Goldberg et al., 1966) where it was shown that
brains of mice did show increased levels of citrate after fluoroacetate poisoning. However these increases were only 2 to 3·5-fold and might not be expected
to slow down appreciably the functioning of the tricarboxylic acid cycle. In
fact the levels of nucleotide phosphates were not appreciably affected.
Lahiri and Quastel (1963) showed in their studies with rat brain slices
that labelling of glutamine by [6- 14 C]glucose as well as by [5- 14 C]glutamate

Table 8.1 RELATIVE SPECIFIC RADIOACTIVITY OF
ACID, L-(U- 14 C]GLUTAMIC ACID, [1- 14 C]SODIUM

GLUTAMINE FROM L-(U- 14 C]ASPARTIC
ACETATE AND NaH 14 C03 IN BRAIN

CORTEX SLICES FROM GUINEA-PIG

Relative specific radioactivity*

[1 4 C]Tracer

Aspartic acid
Aspartic acid

Room temperature
Cold
Incubation
time (min) Untransferred Transferred Untransferred Transferred
10
10

0·40 + 0·23

2·80 + 1·19

1·25 + 0·33

(N = 8)

(N = 9)

(N = 9)

0·94 + 0·20t

2·40 + 0·32t
(N = 2)

(N = 2)

Aspartic acid
Aspartic acid

20
30

1·49 + 0·12t 2·37 + 0·29
(N = 2)
(N = 3)
0·82 + 0·36 1·83 + 0·88
(N

Glutamic acid

10

= 2)

3·41 + 0·88
(N = 10)

(N

= 3)

0·65 + 0·19

1·67 + 0·51

(N = 4)

(N = 6)

1·16 + 0·30t 2·29 + 0·47
(N

= 2)

1·56 + 0·29
(N

= 2)

0·92 + 0·17
(N

=

4)

(N

= 5)

2·01 + 0·40
(N

= 5)

1·70 + 0·34
(N

=

7)

Glutamic acid

20

1·70 + 0·34

Glutamic acid

30

2·14 + 0·85

(N

= 4)

(N = 4)

Sodium acetate
Bicarbonate

10
10

3·50 + 0·07

6·09 + 1·54

(N = 2)

(N = 2)

1·18 + 0·32
(N = 2)

5·87 + 0·32
(N

=

2)

4·30 + 0·37

=

6·28 + 0·09

2)

(N = 4)

1·36 + 0·32

4·08 + 0·32
(N = 2)

(N

(N = 2)

Results are given + S.D. with the specific radioactivity of glutamic acid taken as 1.
N, number of experiments. The tissue and slices were kept either in an ice bath or at
room temperature until incubated at 37°C in Krebs-Ringer phosphate medium containing 1% glucose. Approximately 100 mg of slices and 2·5 ml of medium incubated
with radioactive tracer - 0·5 f.LCi of either labelled glutamate or aspartate ( > 200
1-LCi/f.tmol); 2 f.LCi of labelled acetate (58 1-LCi/1-Lmol) or NaH 14C0 3 (21 f.LCi/ 1-Lmol). The
transferred slices were preincubated for 10 min at 37°C and transferred to fresh medium
before addition of isotope.
* Relative specific radioactivity based on c. p.m./ f.tmol of amino acid.
t Preincubated for 10 min but not transferred to fresh medium before addition of isotope.
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was severely affected by the presence of 1 mM fluoroacetate in the incubation
medium. In view of the evidence for the operation of more than one tricarboxylic acid cycle in brain (Berland Clarke, 1969) it seemed to us that these
paradoxical results could be rationalized if fluoroacetate was a selective inhibitor of that tricarboxylic acid cycle which labels the small pool of glutamate
which is very active in glutamine synthesis. This has been called the 'synthetic' cycle.
In so far as Lahiri and Quastel (1963) measured only the distribution of
radioactivity and did not measure specific radioactivities it was not possible
to use their data directly to test this hypothesis. Our studies with labelled
glutamate, aspartate, y-aminobutyrate and acetate showed that the above
idea of a selective action of fluoroacetate and fluorocitrate on the 'synthetic'
cycle was in fact correct (Table 8.2) (Clarke et al., 1970). With all of these
precursors the labelling of glutamine was selectively inhibited as compared to
that of glutamate.
Table 8.2

EFFECT OF FLUOROACETATE ON THE RELATIVE SPECIFIC RADIOACTIVITY OF GLUTAMINE FROM VARIOUS PRECURSORS

Relative specific radioactivity of glutamine
Control

Precursors
L- [U -14 C]G I utamate
L-[U- 14 C]Aspartate
y- Amino [l- 14 C]butyrate
[1- 14C]Acetate

1·32
3·45
4·45
5·87

+
+
+
+

0·33 (16)
0·80 (12)
1·22 (8)
1·38 (18)

1 mM Fluoroacetate
0· 70
0·38
0·60
0·40

+ 0·04 (2)
+ 0·04 (2)
+ 0·13 (4)

+ 0·03 (3)

Slices were prepared at room temperature and preincubated for 10 min at
37°C either in the presence or absence of 1 mM sodium fluoroacetate
before transfer to fresh medium with or without fluoroacetate. Incubation
time was 10 min at 37°C. See Table 8.1 for other experimental details.

'

Bicarbonate and acetate showed an interesting feature in these in vitro
studies. They yielded glutamine of relative specific radioactivity > 1 even
when incubated with slices prepared in the cold (cf. Table 8.1) (Berl et al.,
1970). Thus, had these been the first labelled precursors studied the effects
of preincubation and transfer of the slices on the synthesis of glutamine
might not have been discovered.
It is still not possible to specify exactly why these treatments have such a
large effect on the labelling of glutamine from most of the precursors studied.
Cold treatment of the slices is observed to have a much greater effect on the
; synthetic' cycle than on the 'energy' cycle. Ouabain, fiuoroacetate and
fiuorocitrate as well as the absence of Ca + + from the incubation medium
all have similar effects (Berl et a!., 1970). It is known that incubation of
slices in the cold causes leakage of potassium ions (Mcilwain and Rodnight,
1962; Terner et a/., 1950). Conversely, increasing the K + concentration of
the medium from 5·4 to 27 mM stimulates the labelling of glutamine from
glutamate (Berl et a!., 1968). Thus one effect of preincubation of the slices
is probably to overcome the depletion of K + . Support of this idea is given
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by the results from experiments with high K + medium where the effects of
cold pretreatment on the labelling of glutamine from glutamate or aspartate
were abolished. However, even slices prepared at room temperature show
enhanced labelling of glutamine after preincubation and transfer to fresh
medium so that K + repletion does not seem to be the complete answer.
This line of investigation has not been followed up further. The above
observations, however, suggest that the energy source for K + movement
may be associated with the 'synthetic' cycle.
Acetate is notable as the only labelled precursor studied by us with which
the pretreatment or method of slice preparation showed no effect on the
relative specific radioactivity of glutamine (Table 8.1) (Berl and Clarke,
1969). However these treatments did affect the total uptake of radioactive
acetate by the slice although they did not affect uptake of aspartate or
glutamate. Hence it would seem that acetate shows the greatest preference
for entry into the 'synthetic cycle'. However this entry is not exclusive for
when the' synthetic' cycle is severely inhibited as with fluoroacetate, glutamate
is still extensively labelled, presumably via the 'energy' cycle.
Brain slices are well known to concentrate glutamate from the incubation
medium against a concentration gradient. However certain inhibitors make
them leaky. Ouabain is one of these (Cremer, 1967; Berl et a!., 1970) and
Li + is another (Berl and Clarke, 1972). Both of these would seem to affect
the 'synthetic' cycle as measured by their effects on the relative specific
radioactivity of glutamine. This is unlikely to be a direct effect on the operation of the tricarboxylic acid cycle but might be related to the association of
K + movement with the 'synthetic' cycle. The common feature of a number of
these treatments viz. cold treatment, incubation with fluoroacetate or fluorocitrate, ouabain or Li +, or omission of Ca + + from the incubation medium
is that they inhibit glutamine formation selectively (Table 8.3) and seem to
be associated with potassium ion movements. It seems that glutamate must
be transported from where it is made to another site for amidation and that
Table 8.3 LABELLING
SLICES IN 20 MIN

Treatment
Control
Ouabain (10 p.M)
Li+ (0·1 M)
No Ca+ +
Fluoroacetate (1 mM)
Fluorocitrate (1 mM)
Control
No Ca+ +
Control
No Ca + +

OF GLUTAMINE RELATIVE TO GLUTAMATE IN GUINEA-PIG BRAIN

Tracer
[1- 14 C]~cetate
[1- 14 C]~cetate
[1- 14 C]~cetate
[1- 14 C]~cetate
[l- 14 C]~cetate
[l- 14 C]~cetate

L-[U- 14 C]Glutamate
L-[U- 14 C]Glutamate
L-[U- 14 C]~spartate
L-[U- 14 C]~spartate

% of
Relative specific
radioactivity in
radioactivity
glutamine Glutamate Glutamine
3·8
0·2
0·5
2·3
0·3
<0·1
1·7
0·2
2·3
0·2

26·4
36·1
33·5
31·2
16·8
11·5
58·8
80·9
20·4
25·5

29·2
1·6
3·5
11·9
1·4
<0·1
20·4
3·4
8·9
1·0
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the energy for this process is associated with the same 'ATP' pool as that
for K + movement. This leads us to suggest that the small pool of glutamate,
active in glutamine formation and associated with the 'synthetic' cycle may
be, at least in part, 'transmitter' glutamate.
Although metabolic inactivation of a transmitter is not essential, it can be
postulated for glutamate. If glutamate released by synaptic transmission
entered the postsynaptic membrane with the influx of sodium it might
encounter glutamine synthetase at the endoplasmic reticulum and be converted to glutamine-an inactive pharmacological agent. In addition glial
cells may act as a buffer to maintain a low concentration of K + in the
immediate extraneural space at areas of synaptic contact (Trachtenberg and
Pollen, 1970; Okamoto and Quastel, 1970). If this uptake of K + is inhibited,
a corresponding inhibition of glutamine synthesis may result even though
the inhibitor has no specific effect on glutamine synthetase, for example
ouabain or fluorocitrate.
So far the discussion has centred largely on the 'synthetic' cycle. An
inhibitor which had its major effect on the 'energy' cycle was aminooxyacetic
acid. This compound is known to inhibit vitamin B6 -dependent processes,
for example transamination and decarboxylation (Wallach, 1961a, b; Baxter
and Roberts, 1961; Rao eta!., 1964; Haber, 1965). The results obtained by
incubating labelled glutamate and aspartate with guinea-pig brain slices in
the presence of this inhibitor confirm this (Table 8.4) (Berl et a!., 1970).
With L-[U- 14 C]aspartate as the labelled precursor less than 1% of the label
appears in glutamate and glutamine while in controls approximately 20% of
the label was found in these two amino acids. With L-[U- 14C]glutamate
Table 8.4

EFFECT OF AMINOOXYACETIC ACID ON BRAIN SLICE
METABOLISM

% of radioactivity
Amino acid
Glutamic acid
Glutamine
Aspartic acid
t

•
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Control

1 mM AOAA

L-[U- 14 C]Glutamic acid
60 + 3 (6)
67 + 3 (4)
23 + 4 (6)
30 + 3 (4)
1 + 1 (4)
5 + 1 (6)
L-[U- 14 C]Aspartic acid
10 + 2 (8)
0

(4)
(4)
1 (4)

Glutamic acid
Glutamine
Aspartic acid

9 + 2 (8)
68 + 3

Glutamic acid
Glutamine
Aspartic acid

[1- 14 C]Acetate
19 + 2 (4)
9 + 1 (4)
37 + 1 (4)
33 + 3 (4)
2 + 1 (4)
<1
(4)

0
100

+

Incubation time was 10 min. See Table 8.1 for other experimental details. Results are percentage of total radioactivity
in the total trichloroacetic acid extract of the tissue slices +
S.D. The number of experiments are indicated in brackets.
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and [l- 14 C]acetate incorporation of radioactivity into aspartate is also
significantly inhibited by incubation in the presence of aminooxyacetic acid.
Another effect of this inhibitor in the presence of [l- 14 C]acetate was to
increase the labelling of glutamine slightly while the labelling of glutamate
was markedly decreased, thus resulting in an increased relative specific radioactivity of glutamine (Table 8.5). The finding that glutamate and glutamine
Table 8.5

EFFECT OF AMINOOXYACETIC ACID ON THE RELATIVE SPECIFIC RADIOACTIVITY OF
GLUTAMINE AND ASPARTIC ACID FROM [1-14C]ACETATE

Aspartic acid

Glutamine

Control
AOAA

10'

20'

30'

10'

20'

30'

6·3 + 0·9
(4)
9·5 + 1·6
(4)

3·8 + 0·5
(3)
7·0 + 1·0
(4)

3·6 + 0·4
(3)
4·9 + 0·7
(4)

0·6 + 0·1
(5)
0·2 + 0·02
(4)

0·7 + 0·1
(4)
0·1 + 0·03
(4)

0·7 + 0·1
(4)
0·2 + 0·05
(4)

Results are averages + S.D. The number of experiments are indicated in brackets. The
specific radioactivity of glutamine and aspartic acid are given relative to that of glutamic
acid. See Table 8.1 for incubation conditions. 1 mM aminooxyacetic acid (AOAA) was
present both in the preincubation and incubation media of the inhibited slices.

continued to be extensively labelled from radioactive acetate indicates that
this is occurring via enzyme systems which do not require pyridoxal phosphate
as coenzyme. The other known enzyme system which allows the synthesis of
glutamate from tricarboxylic acid cycle intermediates without involving transaminases is glutamate dehydrogenase. The importance of this enzyme in
glutamate and glutamine formation was previously indicated in experiments
in which cats were injected in vivo with 15 NH 3 (Berl et al., 1962). These results
taken with the above mentioned selective entry of acetate into the 'synthetic'
cycle reinforce the idea that glutamate dehydrogenase is associated with the
'synthetic' cycle. On the other hand, transaminases would be associated with
the 'energy' cycle and aminooxyacetic acid exerts its effects primarily on this
latter cycle.
Evidence that these different tricarboxylic acid cycles, 'synthetic' and
'energy', may be associated with different types of mitochondria have been
obtained by Neidle et al. (1969). They found that acetate thiokinase and
glutamate dehydrogenase were associated with a less rapidly sedimenting
fraction of mitochondria from rat brain in a sucrose density gradient. The
major fraction of mitochondria was richer in succinic dehydrogenase and
monoamine oxidase. More recently Wilson and Barch (1971) have reported
similar findings. The heavier mitochondria also seem to contain NADPdependent isocitric dehydrogenase.
It is difficult to assess much of the published work on the labelling of amino
acids related to the tricarboxylic acid cycle which have been carried out using
slice preparations because in most of these specific radioactivities were not
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measured. We can guess at some of the levels of amino acids from our
experience and hence calculate approximate specific radioactivities. This is at
best very risky. In addition, in many of the studies even this is not possible,
either because tracer quantities were not used or it could be anticipated
that net changes in the levels of the amino acids had occurred. This is
particularly true when slices are incubated in the absence of glucose. Under
these conditions mathematical analyses assuming an approximate steady state
are not applicable and this is the assumption generally made in our work.
While we rely heavily on alterations in the precursor-product relationships
of glutamate and glutamine to interpret evidence for the existence of compartments of metabolites this is not a prerequisite for such studies but only a
convenience. In fact, in our studies on brain homogenates where we never get
glutamine of higher specific radioactivity than glutamate, it was still possible
to obtain evidence for the compartmentation of the glutamate-glutamine
system. With fluoroacetate or ftuorocitrate the selective inhibition of the
labelling of glutamine is still present. This indicates that the intact cell is not
necessary for the compartmentation of the glutamate-glutamine system to be
manifested in brain (Clarke et al., 1970).
Failure to observe the peculiar precursor product relationships which we
have used so often cannot be taken to prove that compartmentation is not
operational. This approach of looking for relative specific radioactivity ratios
of glutamine greater than one before the peak of radioactive labelling is
dependent on the presence of small highly active pools of glutamate or of its
precursors. Where two different pools of approximately equal size are
involved this experimental stratagem is not useful.
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